Showing results (1361-1370 of 3,185) with videos related to

Sort By:
Pageof 319
Translational Oncology|July 17, 2024
Spatial correlation between in vivo imaging and immunohistochemical biomarkers: A methodological studyHilde J G Smits, Edwin Bennink, Lilian N Ruiter, et al.
Translational Oncology|July 27, 2024
FUBP1 in human cancer: Characteristics, functions, and potential applicationsFan Zhang, Qunli Xiong, Min Wang, et al.
Translational Oncology|August 4, 2024
Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinomaJiezuan Yang, Zhengliang Zhang, Caihong Pang, et al.
Translational Oncology|August 2, 2024
MiR-34b promotes oxidative stress and induces cellular senescence through TWIST1 in human cervical cancerK J Sindhu, Venkatesan Nalini, G K Suraishkumar, et al.
Translational Oncology|August 17, 2024
Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimensQiong Ma, Jin Sun, Qiao Liu, et al.
Translational Oncology|August 19, 2024
Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cellsNa Young Kim, Dukanya Dukanya, Gautam Sethi, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Translational Oncology|August 18, 2024
Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer casesEmmanuella Amoako, Setor Amuzu, Emmanuel Owusu Ofori, et al.
Translational Oncology|July 28, 2024
TAK1 expression is associated with increased PD-L1 and decreased cancer-specific survival in microsatellite-stable colorectal cancerNorman J Galbraith, Jean A Quinn, Sara Sf Al-Badran, et al.
Translational Oncology|July 6, 2024
Cinobufacini enhances the therapeutic response of 5-Fluorouracil against gastric cancer by targeting cancer stem cells via AKT/GSK-3β/β-catenin signaling axisJiejie Sun, Sufeng Zhang, Meng Wang, et al.
Pageof 319